Colgate Raises 2026 Profit Outlook After Q2 Earnings Beat and Margin Gains

Colgate-Palmolive Company CL strengthened its 2026 profit outlook after a second-quarter earnings beat and 140-basis-point gross-margin expansion. Base Business EPS rose 8%, while organic sales growth reflected contributions from both volume and pricing.

The update shifts attention to durability. Management is raising the earnings and margin view while keeping advertising elevated, but higher second-half raw-material and tariff costs and continued North American weakness could absorb part of the operating gains.

CL's Q2 Beat Sets a Stronger Earnings Base

Base Business earnings were 99 cents per share, up 8% year over year and 4.2% above the Zacks Consensus Estimate of 95 cents. Net sales increased 4.9% to $5.36 billion, edging above the consensus mark of $5.35 billion.

Organic sales advanced 2.4%, with organic volume up 0.8% and pricing contributing 1.6%. Worldwide organic volume improved sequentially for a third consecutive quarter, broadening the growth profile beyond pricing alone.

Colgate's 140-Basis-Point Margin Gain Matters

GAAP and Base Business gross profit margin expanded 140 basis points to 61.5%. Revenue growth management, productivity, pricing and mix supported the improvement, giving Colgate more room to absorb inflation and fund growth initiatives.

Base Business operating profit increased 5% to $1.1 billion, while operating margin edged up 10 basis points to 21.4%. Those gains came despite higher selling, general and administrative expenses and continued brand investment.

CL's Raised 2026 Outlook Signals Confidence

Management now expects mid-single-digit Base Business EPS growth in 2026, up from its prior low- to mid-single-digit view. It also improved both GAAP and Base Business gross profit margin outlooks to roughly flat year over year from down previously.

Image Source: Zacks Investment Research

The top-line framework did not change. Colgate still expects net sales growth of 2-6% and organic sales growth of 1-4%, with the latter including the private-label pet food exit. Execution, rather than a higher sales target, is carrying the profit upgrade.

Colgate Is Still Investing Behind Growth

Advertising spending increased 15% to $777 million from $678 million a year ago. Management expects investment to remain elevated in the second half, with premium, science-led innovation and omnichannel demand generation central to the strategy.

The company is funding growth rather than protecting the new earnings target by cutting brand support. That trade-off matters because raw-material and tariff costs are expected to be higher in the second half than in the second quarter.

CL's Regional Divergence Tests the Upgrade

Latin America delivered 5.3% organic sales growth, Asia Pacific posted 5.2% and Europe, Middle East and Africa rose 2%. North America moved the other way, with organic sales down 3% and organic volume declining 3.9%.

The Procter & Gamble Company PG is a useful comparison because its portfolio includes Crest and Oral-B in oral care and major fabric and home-care brands. The Clorox Company CLX provides another household-staples reference point through its cleaning, household and natural personal-care businesses.

Colgate's Rating Mix Tempers the Event

The second-quarter event improved Colgate's profit setup, but it did not remove the main risks. Margin execution and earnings growth have strengthened, while North America, promotional pressure and higher second-half costs keep the outlook balanced.

CL currently carries a Zacks Rank #3 (Hold). It also has a VGM Score of B, Growth Score of B, Momentum Score of B and Value Score of D. The rank is consistent with a hold posture rather than a top-ranked buy signal, while the Style Scores show favorable growth and momentum characteristics but weaker value. The Style Scores complement the Zacks Rank rather than override it. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research